On the Whole, Health Insurers Aren’t – Yet – Fearing COVID-19 Costs: A Review of 2021 Rate Filings

This commentary assesses how insurers are developing their 2021 premium rates by reviewing preliminary actuarial findings in the District of Columbia, New York, Oregon, Vermont, and Washington.

This year, insurers are making projections about health care prices and utilization in the middle of a pandemic and its economic fallout, before anyone has sufficient data to understand fully what the impact of COVID-19 might be.